Towards Healthcare
Veterinary Vaccines Market to Hit USD 17.07 Billion by 2034

Veterinary Vaccines Market Share & Trends 2025 North America Leads with 38%, Asia Pacific Fastest Growing

Projections indicate that, veterinary vaccines industry is projected to rise from USD 9.47 billion in 2024 to USD 17.07 billion by 2034, reflecting a CAGR of 6.07% over the next decade. The veterinary vaccines market is growing due to rising pet adoptions, increasing livestock production, and heightened awareness of animal disease prevention. North America is leading the market due to the growing adoption of stray animals.

  • Insight Code: 6032
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The veterinary vaccines market stands at USD 10.04 billion in 2025 and is expected to reach USD 17.07 billion by 2034, growing at a CAGR of 6.07% from 2024 to 2034.

North America is leading the veterinary vaccines market due to robust livestock production, high pet ownership rates, advanced veterinary healthcare infrastructure, the presence of leading vaccine manufacturers, and strong regulatory frameworks that support innovation and quality assurance. 

The veterinary vaccines market includes segments such as by animal type, by vaccine type/technology, by platform formulation, by indication/disease category, by distribution channel/end user, and by region.

Key trends include integration of AI and predictive analytics in vaccine R&D, government-led One Health bird flu vaccination programs, field-tested efficacy studies for avian flu vaccines, innovations in recombinant and DNA mRNA vaccines, and increasing focus on zoonotic disease prevention to safeguard both animal and human health. 

USDA (United States Department of Agriculture) EMA (European Medicines Agency) CDSCO (India) Ministry of Fisheries, Animal Husbandry & Dairying, Government of India World Health Organization (WHO) Food and Agriculture Organization (FAO) World Bank Centers for Disease Control and Prevention (CDC).